Standard of care for adult Wilms tumor? From adult urologist to pediatric oncologist. A retrospective review.


Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 26 05 2020
revised: 10 09 2020
accepted: 22 09 2020
pubmed: 2 11 2020
medline: 20 2 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Nephroblastoma or Wilms tumor, a common embryonal tumor in children, can occasionally occur in adults. The survival of patients older than 18 years is reported to be significantly inferior to that of pediatric patients. Establishing a diagnosis for these rare tumors can be challenging for both clinicians and pathologists, who are not accustomed to considering Wilms tumor as a potential differential in adults. This leads to misdiagnosis and a subsequent delay in the initiation of appropriate therapy. The standard of care is not well established for Wilms tumors in adults. We provide here a comprehensive review of the international literature on the subject with the current management protocols in France. We also propose the need of strong inter-disciplinary collaboration between surgeons, pathologists, and medical and pediatric oncologists for increasing knowledge and formulating treatment strategies for these rare tumors. Homogenous guidelines for treating adults with Wilms tumors have been proposed for all patients in France.

Identifiants

pubmed: 33129487
pii: S0007-4551(20)30405-7
doi: 10.1016/j.bulcan.2020.09.007
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

177-186

Informations de copyright

Copyright © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Hélène Sudour-Bonnange (H)

Oscar-Lambret center, department of pediatric oncology, AYA unit, Lille, France. Electronic address: h-sudour@o-lambret.fr.

Aurore Coulomb-Lherminé (A)

Trousseau hospital, department of pathology, Paris, France.

Jean Christophe Fantoni (JC)

CHRU Lille, department of urologic surgery, Lille, France.

Alexandre Escande (A)

Oscar-Lambret center, department of radiotherapy, Lille, France.

Hervé J Brisse (HJ)

Institut Curie, department of imaging, Paris, France.

Estelle Thebaud (E)

CHRU Nantes, department of pediatric hemato-oncology, Nantes, France.

Arnaud Verschuur (A)

AP-HM, La Timone Children's hospital, department of pediatric oncology and hematology, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH